BPS Publications Aims Ganciclovir (GCV) is commonly used to treat cytomegalovirus (CMV) infections in immunocompromised children. Currently, the therapeutic target for effective treatment is unclear: Adult studies s...

Pkpd study in immunocompromised kids showing GCV AUC24 corresponding to 90% maximal suppression and elimination effects was approximately 40-100 mg/L·h. WCC significantly affected the viral decline rate. Time for routine tdm? bpspubs.onlinelibrary.wiley.com/doi/10.1002/... #cmv #pedsid #TxIDChat

Reminder for those at the Fred Hutch Symposium! Join us for lunch on Tues 5/13 at noon in the Portland room for a live #TxIDChat. This session is geared for trainees/early career but all are welcome. Q&A will follow at the end as well! #IDSky

We are SO excited to bring a #TxIDChat to the real world!! This is going to be a fun one. I hope you can join us if you’re there! #IDSky (also thrilled to have @rebeccakumar.bsky.social as co-pilot 👯‍♀️

image promoting TxID ECN live TxID Chat event at the Fred Hutch ID Symposium on May 13th

Attending the Fred Hutch Infectious Diseases in the Immunocompromised Host Symposium? Join us over lunch on Tues May 13th for a LIVE #TxIDChat with fantastic panelists on how to get the most out of attending an ID conference! @rebeccakumar.bsky.social @chelseagorsline.bsky.social #IDSky #TxID

Social Media Savvy, It's More Than Just the #Hashtags: How the Use of Social Media in Transplant Infectious Diseases Can Impact the Field and Patients

‼️Our new paper on social media in #TxID is officially out in @thetxidjournal.bsky.social

We summarize findings from our #TxIDChat @txidfellows.bsky.social

We discuss recs for trainees, career advancement, & future directions in this changing landscape. Check it out!

dx.doi.org/10.1111/tid....

Thanks to all for joining us for our first #TxIDChat on Bluesky. Let us know if you have ideas or comments for future #TxIDChats!

I’d love to have a serum Aspergillus PCR. We have a diagnostic stewardship group that helps monitor use of these tests which has been helpful to steer more appropriate use. #TxIDChat

A5. For a while we used Viracor’s fungal plus PCR BAL test (Aspergillus, Mucor, Nocardia) pretty broadly. Until we analyzed our data and realized it wasn’t that helpful clinically and we stopped (still can add on as desired). Karius is highly regulated due to cost, we don’t use often. #TxIDChat

Remember to tag your response with #TxIDChat so others can follow along!
@germatologist.bsky.social @ricardolahozmd.bsky.social @hannah-imlay.bsky.social @apuid.bsky.social @jessicalittlemd.bsky.social @annaapostolopoulou.bsky.social @pedsoncid.bsky.social @akaraba.bsky.social

Q6. Other: As we enter a new era of #IDSky on Bluesky, what else can @TxID-Fellows offer the #TxID community? For instance, a #TxID specific Journal Club hosted on Bluesky, or other collaborations? #TxIDChat
@michaelisonmd.bsky.social @germhuntermd.bsky.social @docwoc71.bsky.social

Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future? Background The use of machine learning (ML) in infectious diseases is expanding. Objectives This review aims to provide an overview of the literature on ML for clinical decision support in antimic...

I truly enjoy this paper illustrating the potential for personalized antimicrobial decision making in #Transplant patients. Any tool to help reduce the guesswork in #antimicrobial prescribing is appreciated. #TxIDChat

onlinelibrary.wiley.com/doi/epdf/10....

Remember to tag your response with #TxIDChat so others can follow along!
@jenncuellarr.bsky.social @docwoc71.bsky.social @pergamic.bsky.social @kottonnelson.bsky.social @handleyg.bsky.social @jobadd.bsky.social @jessicalittlemd.bsky.social @aussiedocwolfe.bsky.social @tina-ichid.bsky.social

Q5. Advanced Diagnostics: How are you using advanced diagnostics in your #TxID practice? How do we balance these tests with diagnostic stewardship? #TxIDChat
@germhuntermd.bsky.social @maricarmalinis.bsky.social @arunasubramanian.bsky.social @fungaldoc.bsky.social @joshhillmd.bsky.social

I think with regards to risk counseling we (TxID) have become less dogmatic and generally more open to counseling on harm reduction. #TxIDChat

#TxIDChat

Remember to tag your response with #TxIDChat so others can follow along!
@jenncuellarr.bsky.social @sarabelga.bsky.social @doucette-karen.bsky.social @eliarant.bsky.social @donvinh.bsky.social @aneeshkmehta.bsky.social @aussiedocwolfe.bsky.social @jschaenmanmd.bsky.social @transplantid.bsky.social

Q4. Personalized Medicine: What opportunities exist for the use of personalized medicine in #TxID? For instance, individualized approaches to prophylaxis and management of infections, etc? #TxIDChat
@kottonnelson.bsky.social @maricarmalinis.bsky.social @davidvanduin.bsky.social @akaraba.bsky.social

That’s very enterprising! I like that we are recognizing how different platform / modalities are useful to different learners. #TxIDChat

A3. No we are nowhere near that stage. I personally have ethical concerns about it, particularly with so many unanswered questions on infection transmission and subsequent management. Def appreciate the bold people working on this though! #TxIDchat

Remember to tag your response with #TxIDChat so others can follow along!
@pearliechong.bsky.social @davidvanduin.bsky.social @aussiedocwolfe.bsky.social @jschaenmanmd.bsky.social @aneeshkmehta.bsky.social @fungalspore.bsky.social @alyssaammazz.bsky.social @annaapostolopoulou.bsky.social

Q3. Xenotransplantation: Is your institution exploring xenotransplantation as a viable alternative to human organ donation? What do you view as the major infectious barriers and/or risks surrounding xenotransplantation? #TxIDChat
@kottonnelson.bsky.social @jobadd.bsky.social

A2. We have a website for general ID with videos and some questions. My colleague Rachel Sigler has an app she built for stewardship education for med students, is considering building one for global/public health/ID as well. Rachel also has donor call simulation #TxIDChat

We have been using Factile to create jeopardy and that’s been particularly fun way of learning medicine! #TxIDChat

Remember to tag your response with #TxIDChat so others can follow along!
@maricarmalinis.bsky.social @docwoc71.bsky.social @courtharrismd.bsky.social
@ealtneu.bsky.social @amishkin.bsky.social @shipragoelmd.bsky.social @leegott.bsky.social @tina-ichid.bsky.social @akaraba.bsky.social

Q2. Virtual Education: If at an academic center, does your program utilize novel educational modalities (i.e. podcasts; gamification)? If so, what infrastructure and/or funding is in place to support this type of curriculum development? #TxIDChat
@tmccarty2010.bsky.social @ricardolahozmd.bsky.social

So interesting! Recently talked to our Epic data analytics team. There’s definitely talk about laying down the foundation w/ data from EMR (Epic) to feed into using AI. Potentially in prediction and planning. Eg #antibiotic high use pop’n such as #transplant. #TxIDChat

I'm behind the times on adopting AI; I'm curious what others are using/doing! #TxIDChat #IDSky #MedSky

A1. We’ve had a partial roll out of an AI microphone that listens in on clinic visits and summarizes them for you. It has not been offered to ID, but my colleague is using it in her hepatology clinic with mixed success. I’m a fan of Mayo’s OpenEvidence AI app for clinical info.
#TxIDChat

Hi! Miranda So. ASP manager at the University Health Network in Toronto 🇨🇦. I’m
a PharmD who specializes in #AMS in #Transplant patients.
#TxIDChat

Remember to tag your response with #TxIDChat so others can follow along! @orlamorrissey.bsky.social @pearliechong.bsky.social @aneeshkmehta.bsky.social @ricardolahozmd.bsky.social @davidvanduin.bsky.social @hannah-imlay.bsky.social @maricarmalinis.bsky.social @arunasubramanian.bsky.social